Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy.

Conclusion. Superior IOP control was achieved with TTFC in patients with OAG or OHT previously uncontrolled with beta-blockers. No new safety findings were identified. This trial is registered with ClinicalTrials.gov NCT02003391. PMID: 28239491 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28239491?dopt=Abstract

Source: Journal of Ophthalmology - February 28, 2017 Category: Opthalmology Tags: J Ophthalmol Source Type: research